Better pharmacotherapy in heart failure with reduced ejection fraction may partly explain the obesity paradox.
作者信息
Carbone Salvatore, Elagizi Andrew, Lavie Carl J
机构信息
Department of Kinesiology & Health Sciences, College of Humanities & Sciences, Virginia Commonwealth University, Richmond, VA, USA.
Division of Cardiology, Pauley Heart Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
出版信息
Eur J Heart Fail. 2023 May;25(5):711-713. doi: 10.1002/ejhf.2832. Epub 2023 Apr 10.
Abstract
摘要
相似文献
1
Better pharmacotherapy in heart failure with reduced ejection fraction may partly explain the obesity paradox.射血分数降低的心力衰竭患者中更好的药物治疗可能部分解释了肥胖悖论。
Eur J Heart Fail. 2023 May;25(5):711-713. doi: 10.1002/ejhf.2832. Epub 2023 Apr 10.
2
Obesity Paradox among Heart Failure with Reduced Ejection Fraction Patients: A Retrospective Cohort Study.射血分数降低的心力衰竭患者中的肥胖悖论：一项回顾性队列研究。
Medicina (Kaunas). 2022 Dec 28;59(1):60. doi: 10.3390/medicina59010060.
3
Absence Of An Obesity Paradox in Patients With Heart Failure With Reduced Ejection Fraction Participating in Phase II Cardiac Rehabilitation.射血分数降低的心力衰竭患者参与心脏康复二期时不存在肥胖悖论
J Cardiopulm Rehabil Prev. 2021 Jul 1;41(4):288-289. doi: 10.1097/HCR.0000000000000595.
4
The obesity paradigm on outcome in heart failure with reduced ejection fraction.
Eur Heart J. 2024 Apr 21;45(16):1484-1485. doi: 10.1093/eurheartj/ehad761.
5
The obesity paradigm on outcome in heart failure with reduced ejection fraction.
Eur Heart J. 2024 Apr 21;45(16):1486. doi: 10.1093/eurheartj/ehad764.
6
Reply to: 'Why do obese patients with heart failure with reduced ejection fraction have better outcomes from pharmacological treatments?'.回复：“为什么射血分数降低的肥胖心力衰竭患者药物治疗效果更好？”
Eur J Heart Fail. 2023 Jun;25(6):922-923. doi: 10.1002/ejhf.2880. Epub 2023 May 8.
7
A novel mechanism of heart failure with normal ejection fraction.射血分数正常的心力衰竭的一种新机制。
Heart. 2008 Apr;94(4):446-9. doi: 10.1136/hrt.2006.114082. Epub 2007 May 4.
8
The Obesity Paradox in Heart Failure: Is It Still Valid in Light of New Therapies?心力衰竭中的肥胖悖论：鉴于新疗法，它是否仍然成立？
Cardiology. 2022;147(5-6):529-538. doi: 10.1159/000527332. Epub 2022 Oct 4.
9
Heart failure with preserved left ventricular ejection fraction: concepts, misconceptions and future directions.射血分数保留的心力衰竭：概念、误解与未来方向
Blood Press. 2011 Jun;20(3):129-33. doi: 10.3109/08037051.2010.542642. Epub 2010 Dec 8.
10
Letter to the Editor - New Pharmacotherapy for Heart Failure with Reduced Ejection Fraction.
Expert Rev Cardiovasc Ther. 2020 Sep;18(9):651-652. doi: 10.1080/14779072.2020.1799562. Epub 2020 Aug 1.
引用本文的文献
1
Dietary Interventions in Heart Failure With Preserved Ejection Fraction: A Scoping Review.射血分数保留的心力衰竭的饮食干预：一项范围综述
JACC Adv. 2024 Dec 17;4(1):101465. doi: 10.1016/j.jacadv.2024.101465. eCollection 2025 Jan.
2
Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction.射血分数轻度降低的心力衰竭患者的年龄相关结局
J Clin Med. 2024 Aug 30;13(17):5151. doi: 10.3390/jcm13175151.
本文引用的文献
1
Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry.心力衰竭合并射血分数降低的肥胖与非肥胖患者心力衰竭药物治疗的使用情况及其与结局的相关性：来自瑞典心力衰竭注册登记处的数据。
Eur J Heart Fail. 2023 May;25(5):698-710. doi: 10.1002/ejhf.2795. Epub 2023 Mar 6.
2
Weighing in on weight loss in heart failure with reduced ejection fraction.对射血分数降低的心力衰竭患者体重减轻的探讨
Eur J Heart Fail. 2023 Jan;25(1):128-130. doi: 10.1002/ejhf.2753. Epub 2023 Jan 4.
3
Updates on obesity and the obesity paradox in cardiovascular diseases.肥胖与心血管疾病中肥胖悖论的研究进展。
Prog Cardiovasc Dis. 2023 May-Jun;78:2-10. doi: 10.1016/j.pcad.2022.11.013. Epub 2022 Dec 5.
4
Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction.与非肌肉减少性肥胖相比，射血分数降低的心力衰竭患者中存在肌肉减少性肥胖与心肺功能降低相关。
Circ Heart Fail. 2022 Oct;15(10):e009518. doi: 10.1161/CIRCHEARTFAILURE.122.009518. Epub 2022 Sep 13.
5
Physical activity, sedentary behaviors and all-cause mortality in patients with heart failure: Findings from the NHANES 2007-2014.体力活动、久坐行为与心力衰竭患者全因死亡率：来自 2007-2014 年 NHANES 的研究结果。
PLoS One. 2022 Jul 15;17(7):e0271238. doi: 10.1371/journal.pone.0271238. eCollection 2022.
6
Effects of Replacing Sedentary Time With Physical Activity on Mortality Among Patients With Heart Failure: National Health and Nutrition Examination Survey Follow-Up Study.用身体活动代替久坐时间对心力衰竭患者死亡率的影响：国家健康和营养调查随访研究。
Mayo Clin Proc. 2022 Oct;97(10):1897-1903. doi: 10.1016/j.mayocp.2022.05.009. Epub 2022 Jun 23.
7
Obesity treatment: Weight loss versus increasing fitness and physical activity for reducing health risks.肥胖治疗：减肥与增强体质及增加身体活动以降低健康风险的比较
iScience. 2021 Sep 20;24(10):102995. doi: 10.1016/j.isci.2021.102995. eCollection 2021 Oct 22.
8
The sodium-glucose co-transporter 2 inhibitor dapagliflozin improves prognosis in systolic heart failure independent of the obesity paradox.钠-葡萄糖协同转运蛋白2抑制剂达格列净可改善收缩期心力衰竭的预后，且独立于肥胖悖论。
Eur J Heart Fail. 2021 Oct;23(10):1673-1676. doi: 10.1002/ejhf.2336. Epub 2021 Sep 9.
9
Implications of obesity across the heart failure continuum.肥胖对心力衰竭连续体的影响。
Prog Cardiovasc Dis. 2020 Sep-Oct;63(5):561-569. doi: 10.1016/j.pcad.2020.09.005. Epub 2020 Sep 28.
10
Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.成年人肥胖和重度肥胖的患病率：美国，2017-2018 年。
NCHS Data Brief. 2020 Feb(360):1-8.
Zotero 插件